William Forbes
Director/Board Member presso BEYOND AIR, INC.
Patrimonio netto: 255 409 $ in data 31/03/2024
Profilo
William P.
Forbes founded Vivelix Pharmaceuticals, Ltd.
in 2016, where he worked as President & Chief Executive Officer.
Dr. Forbes also currently works at Beyond Air, Inc., as Independent Director from 2018, Beyond Air Ltd., as Director from 2018, Hallux, Inc., as Director from 2018, and Heron Therapeutics, Inc., as Chief Development Officer & Executive VP from 2023.
Dr. Forbes also formerly worked at Salix Pharmaceuticals Ltd., as President-Medical, Research & Development in 2015, Metabasis Therapeutics, Inc., as VP, Clinical Development & Regulator Affairs in 2004, Otsuka America Pharmaceutical, Inc., as Group Leader, Glaxo, Inc., as Senior Clinical Research Scientist, and Trevi Therapeutics, Inc., as Chief Development Officer from 2021 to 2022.
Dr. Forbes received his doctorate degree from Creighton University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
HERON THERAPEUTICS INC
0.06% | 19/04/2024 | 82 874 ( 0.06% ) | 229 561 $ | 31/03/2024 |
BEYOND AIR, INC.
0.04% | 20/03/2024 | 14 855 ( 0.04% ) | 25 848 $ | 31/03/2024 |
Posizioni attive di William Forbes
| Società | Posizione | Inizio |
|---|---|---|
| BEYOND AIR, INC. | Director/Board Member | 13/08/2018 |
| HERON THERAPEUTICS, INC. | Corporate Officer/Principal | 06/06/2023 |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Director/Board Member | 01/01/2018 |
Hallux, Inc.
 Hallux, Inc. Pharmaceuticals: MajorHealth Technology Hallux, Inc. provides pharmaceutical services. It develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis. The company was founded by Mark T. Taylor, Jay Edward Birnbaum, Hendrik Arend Kroon and Robert Orr in 2012 and is headquartered in Laguna Hills, CA. | Director/Board Member | 01/11/2018 |
Precedenti posizioni note di William Forbes
| Società | Posizione | Fine |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2022 |
| SALIX PHARMACEUTICALS, LTD. | Chief Tech/Sci/R&D Officer | 01/06/2015 |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | General Counsel | 01/01/2004 |
Vivelix Pharmaceuticals, Ltd.
 Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Vivelix Pharmaceuticals, Ltd. manufactures and sells pharmaceutical products. The private company is based in Hamilton, BM. and has subsidiaries in the United States. The Bermudian company was founded by William P. Forbes. | Chief Executive Officer | - |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
Formazione di William Forbes
| Creighton University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| TREVI THERAPEUTICS, INC. | Health Technology |
| BEYOND AIR, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
| Glaxo, Inc. | |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Health Technology |
Hallux, Inc.
Hallux, Inc. Pharmaceuticals: MajorHealth Technology Hallux, Inc. provides pharmaceutical services. It develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis. The company was founded by Mark T. Taylor, Jay Edward Birnbaum, Hendrik Arend Kroon and Robert Orr in 2012 and is headquartered in Laguna Hills, CA. | Health Technology |
Vivelix Pharmaceuticals, Ltd.
Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Vivelix Pharmaceuticals, Ltd. manufactures and sells pharmaceutical products. The private company is based in Hamilton, BM. and has subsidiaries in the United States. The Bermudian company was founded by William P. Forbes. | Health Technology |
- Borsa valori
- Insiders
- William Forbes
